Neonatal alloimmune thrombocytopenia (NAIT) is a rare yet potentially life‐threatening condition caused by maternal sensitisation to fetal platelet antigens, most notably human platelet antigen 1a.
When a newborn requires surgery, the question of how to manage bleeding becomes more complicated than it is for adults or ...
Abstract and Introduction Review of Normal Platelet Physiology and Megakaryocytopoisis Qualitative Platelet Abnormalities Conclusion References Nitric oxide (NO) is another drug used in the neonatal ...
Microgels mimic the mechanical properties of natural platelets to maximize the ability of the B peptides to create fibrin ...
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with ...
BillionToOne Expands Its Leadership in Hemolytic Disease of the Fetus and Newborn (HDFN) and Extends Fetal Antigen Testing to Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) MENLO PARK, Calif., ...
-- Preliminary data from the ongoing Phase 1b study shows RLYB212 rapidly and completely eliminates transfused HPA-1a positive platelets -- -- Proof-of-Concept Data Expected in 1Q 2023-- NEW HAVEN, ...
Maternal prothrombin time measured at delivery was the only independent maternal laboratory predictor of neonatal sepsis in ...
Platelets are small types of blood cells that prevent excessive bleeding. It’s possible to develop low or high platelet counts related to a number of health conditions. Platelets are one of the main ...
Thrombocytopenia and hemophilia are two conditions that can affect the body’s ability to form blood clots. Although they have similar symptoms, they have different causes and treatments. When a person ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results